The objective of this project is to elucidate the mechanism by which endogenous opiate peptides are metabolized. This research will focus on elucidating the physiological role of two enkephalin degrading enzymes; a membrane endopeptidase (enkephalinase) cleaving enkephalins at the gly-phe bond and a recently described membrane bound puromycin insensitive aminopeptidase. Multiple forms of the membrane endopeptidase have been demonstrated to exist in rat brain. These multiple forms will be isolated and compared to each other in terms of their physical properties. These studies are designed to elucidate differences in these multiple enkephalinase forms due to differences in either primary structure or glycosylation. The substrate specificity of each enkephalinase form will be examined in terms of various opiate peptides and other biologically active non-opiate peptides. Monoclonal antibodies specific for each of the enkephalinase forms will be produced and used in immunohistochemical localization studies. These studies are designed to determine whether the multiple enkephalinase forms have a differential distribution in brain and to correlate enkephalinase distribution with that of opiate peptides and opiate receptors. Studies with the membrane puromycin insensitive aminopeptidase will parallel those to be conducted with the endopeptidase. These studies will include characterization of the enzyme in terms of its physical properties and substrate specificity, and the use of antibodies produced against the enzyme for immunohistochemical localization studies. Taken together these studies should help to elucidate the physiological role of these peptidases in the metabolism of endogenous enkephalins and other opiate peptides. In addition, these studies should help in assessing the importance of these enzymes in regulating opiate peptide levels """"""""in vivo"""""""".

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002243-08
Application #
3207198
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1978-09-30
Project End
1986-02-28
Budget Start
1985-03-01
Budget End
1986-02-28
Support Year
8
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Overall Medical
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Guan, Hanjun; Chow, K Martin; Song, Eunsuk et al. (2015) The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells. PLoS One 10:e0133263
Song, Eun Suk; Ozbil, Mehmet; Zhang, Tingting et al. (2015) An Extended Polyanion Activation Surface in Insulin Degrading Enzyme. PLoS One 10:e0133114
Sexton, Travis; Hitchcook, Lisa J; Rodgers, David W et al. (2012) Active site mutations change the cleavage specificity of neprilysin. PLoS One 7:e32343
Guan, H; Chow, K M; Shah, R et al. (2012) Degradation of islet amyloid polypeptide by neprilysin. Diabetologia 55:2989-98
Noinaj, Nicholas; Song, Eun Suk; Bhasin, Sonia et al. (2012) Anion activation site of insulin-degrading enzyme. J Biol Chem 287:48-57
Song, Eun Suk; Melikishvili, Manana; Fried, Michael G et al. (2012) Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation. PLoS One 7:e46790
Song, Eun Suk; Rodgers, David W; Hersh, Louis B (2011) Mixed dimers of insulin-degrading enzyme reveal a cis activation mechanism. J Biol Chem 286:13852-8
Chirra, Hariharasudhan D; Sexton, Travis; Biswal, Dipti et al. (2011) Catalase-coupled gold nanoparticles: comparison between the carbodiimide and biotin-streptavidin methods. Acta Biomater 7:2865-72
Noinaj, Nicholas; Bhasin, Sonia K; Song, Eun Suk et al. (2011) Identification of the allosteric regulatory site of insulysin. PLoS One 6:e20864
Shen, Xin-Ming; Crawford, Thomas O; Brengman, Joan et al. (2011) Functional consequences and structural interpretation of mutations of human choline acetyltransferase. Hum Mutat 32:1259-67

Showing the most recent 10 out of 96 publications